Applied Molecular Transport Inc. Common Stock
AMTI
AMTI was delisted on the 26th of December, 2023.
77 hedge funds and large institutions have $215M invested in Applied Molecular Transport Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 24 increasing their positions, 26 reducing their positions, and 19 closing their positions.
502% more call options, than puts
Call options by funds: $1.5M | Put options by funds: $249K
1.64% more ownership
Funds ownership: 71.63% → 73.27% (+1.6%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
8% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 26
7% less funds holding
Funds holding: 83 → 77 (-6)
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
44% less capital invested
Capital invested by funds: $385M → $215M (-$170M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
+$8.53M |
| 2 |
Morgan Stanley
New York
|
+$3.87M |
| 3 |
Renaissance Technologies
New York
|
+$2.11M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$1.5M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$1.24M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital International Investors
Los Angeles,
California
|
-$10.8M |
| 2 |
Millennium Management
New York
|
-$2.66M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.22M |
| 4 |
HF
HRT Financial
New York
|
-$901K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$839K |
AMTI Hedge Fund Activity: Q1 2022 in Review
77 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Applied Molecular Transport Inc. Common Stock (AMTI) for Q1 2022, worth a combined $215M — down 44% from $385M a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of AMTI and 14 opened new positions — a net loss of 5 holders — while 26 trimmed existing stakes and 24 added.
The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $8.53M. The largest seller was Capital International Investors, exiting entirely with an estimated $10.8M sold.
- 77 institutional investors held Applied Molecular Transport Inc. Common Stock (AMTI) as of Q1 2022, down from 83 in Q4 2021.
- Funds reported $215M of Applied Molecular Transport Inc. Common Stock stock for Q1 2022, down 44% quarter-over-quarter.
- 14 funds opened new Applied Molecular Transport Inc. Common Stock positions in Q1 2022 and 19 closed out, a net change of -5 holders.
- The largest Applied Molecular Transport Inc. Common Stock buyer in Q1 2022 was Avoro Capital Advisors, an estimated $8.53M added.
- The largest Applied Molecular Transport Inc. Common Stock seller in Q1 2022 was Capital International Investors, an estimated $10.8M sold.
Based on aggregated 13F filings for Q1 2022.